CN | EN

About Us

Sound Biopharmaceuticals is an innovation-driven biopharmaceutical company sponsored leading by Nobel Prize laureate, dedicated to the discovery and development of innovative biologics focusing on oncology and immunology, as well as clinical research and commercialization globe wide.

The company has built complete molecular biology, cell biology, structural biology, drug evaluation, protein engineering laboratories, built a series of leading technology platforms including monoclonal antibody screening, antibody humanization and optimization, protein production and purification, and ADICT bispecific technology.

Our Mission

Harness science for pioneering breakthrough in antibody-based therapeutics

Senior Management

  • Qing Li, MD/PhD Founder/Chief Executive Officer

    Dr. Li received his PhD in clinical immunology from the Chinese University of Hong Kong. He completed his postdoctoral training at Stanford University. Prior to founding the company, Dr. Li served as a Professor of Immunology at Sun Yat-sen University. In 2015, Dr. Li founded Ascenta Biosciences which was acquired two years later.

  • Zhong Wang, PhD Chief Scientific Officer

    Dr. Wang obtained his PhD in Biochemistry and Molecular Biology at Indiana University. Then he was a postdoctoral fellow, Research Associate, and Instructor at Stanford University. And later he was a scientist focusing on drug discovery at Amgen. Before joining Soundbio, Dr. Wang served as a professor at Sun Yat-sen University. Dr. Wang has published more than 30 SCI papers, including Nature and Cancer Cell.

  • Fanxin Ma, PhD Co-founder/Chief Technical Officer

    Dr. Ma received his PhD in cellular biology from Arizona University and Sichuan University. He ever worked as a senior scientist, laboratory director and project manager in Simcere Pharmaceuticals, and then served as the Director of the Institute of Biopharma in Humanwell Pharmaceuticals Group.

  • Shoubin Wen, MD Chief Medical Officer

    Dr. Wen received his MD from Nanjing Medical University, and continued his training in MD Anderson Cancer Center and University of Calgary. Before joining Soundbio, he served as the leader of Medical Science Liaison team at AstraZeneca and then the Director of Clinical Research in oncology at Sanofi.

  • Ying Huang, PhD Vice President

    Dr. Huang received her bachelor degrees in Chemistry and Economics from Peking University, and PhD in Chemistry from Texas A&M University. Before joining Soundbio, she worked as the Senior R&D Director at Hanxbio pharmaceuticals. Dr. Huang is responsible for the key technology research and management of the projects, technology platform and IND filing.

Chief scientist of the Scientific Advisory Board

  • Roger Kornberg, PhD

    Roger Koenberg is a professor of structural biology at Stanford University, a Nobel laureate in chemistry in 2006 and an academician of the National Academy of Sciences. Professor Koenberg is not only a biochemist, but also a structural chemist and geneticist. He has published over 240 academic papers, including more than 50 articles in the top three scientific journals, Cell, Science, and Nature. Professor Koenberg and Dr. Qing Li co-founded Sound BioPharma in 2017. He served as the Chief Scientist of Scientific Advisory Board of the company.